Your browser doesn't support javascript.
loading
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.
Vitanza, Nicholas A; Johnson, Adam J; Wilson, Ashley L; Brown, Christopher; Yokoyama, Jason K; Künkele, Annette; Chang, Cindy A; Rawlings-Rhea, Stephanie; Huang, Wenjun; Seidel, Kristy; Albert, Catherine M; Pinto, Navin; Gust, Juliane; Finn, Laura S; Ojemann, Jeffrey G; Wright, Jason; Orentas, Rimas J; Baldwin, Michael; Gardner, Rebecca A; Jensen, Michael C; Park, Julie R.
Afiliación
  • Vitanza NA; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA. nicholas.vitanza@seattlechildrens.org.
  • Johnson AJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle, WA, USA. nicholas.vitanza@seattlechildrens.org.
  • Wilson AL; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Brown C; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Yokoyama JK; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Künkele A; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Chang CA; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Rawlings-Rhea S; Therapeutic Cell Production Core, Seattle Children's Research Institute, Seattle, WA, USA.
  • Huang W; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Seidel K; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Albert CM; Department of Pediatric Oncology and Hematology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Pinto N; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Gust J; Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Finn LS; Office of Animal Care, Seattle Children's Research Institute, Seattle, WA, USA.
  • Ojemann JG; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Wright J; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Orentas RJ; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
  • Baldwin M; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Gardner RA; Seattle Children's Therapeutics, Seattle, WA, USA.
  • Jensen MC; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle, WA, USA.
  • Park JR; Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, USA.
Nat Med ; 27(9): 1544-1552, 2021 09.
Article en En | MEDLINE | ID: mdl-34253928

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Glioblastoma / Receptor ErbB-2 / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Glioblastoma / Receptor ErbB-2 / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos